A recent ruling by the United States Court of Federal Claims has dismissed a claim made by Lynn Peterson, who alleged that the Pneumococcal 13-Valent Conjugate vaccine, known as Prevnar-13, caused her to develop Guillain-Barré Syndrome (GBS). The decision, issued by Special Master Christian J. Moran, concluded that Peterson did not provide enough evidence to support her claim. This ruling affects Peterson and potentially sets a precedent for similar vaccine injury claims in the future.
The case, filed under docket number 21-1778V, began when Peterson submitted her petition on August 31, 2021. She claimed that the Prevnar-13 vaccine she received on February 1, 2019, led to her diagnosis of Guillain-Barré Syndrome. The Vaccine Injury Compensation Program (VICP) allows individuals to seek compensation for injuries allegedly caused by vaccines, but claimants must meet specific legal standards to succeed.
In this case, Peterson's claim was met with opposition from the Secretary of Health and Human Services, who filed a report recommending that compensation be denied. The Secretary argued that Peterson had not met the necessary burden of proof required under the VICP. The case proceeded through various stages, including the submission of medical records and expert reports from both parties. Peterson relied on the opinion of Dr. Steinman, while the Secretary presented reports from Dr. Whitton and Dr. Jamieson.
As the case progressed, it became clear that it was intertwined with other similar cases, particularly one known as Gamboa-Avila, which also involved the Prevnar-13 vaccine and Guillain-Barré Syndrome. The Federal Circuit had not yet made a decision in Gamboa-Avila, leading to a stay in Peterson's case while awaiting the outcome. In February 2026, the Federal Circuit affirmed the denial of compensation in Gamboa-Avila, which influenced the proceedings in Peterson's case.
On June 1, 2026, just days before a scheduled response deadline, Peterson and the Secretary filed a joint stipulation for dismissal, indicating that both parties agreed to dismiss the case. The court ruled that there was insufficient evidence to support Peterson's claim. The ruling stated, "Ms. Peterson has not presented any such argument, and instead filed a joint stipulation of dismissal. Accordingly, this case is dismissed for insufficient evidence."
In the decision, Judge Moran emphasized the burden of proof required under the VICP. He noted that petitioners must demonstrate a causal connection between the vaccine and the injury they claim to have suffered. This includes showing a medical theory that links the vaccination to the injury, a logical sequence of cause and effect, and a temporal relationship between the vaccination and the injury. The court found that Peterson had not met these requirements.
The impact of this ruling extends beyond Peterson's individual case. It reinforces the challenges that claimants face when seeking compensation for vaccine-related injuries. The court's decision highlights the importance of providing robust medical evidence and expert testimony to support claims under the VICP. Additionally, it may influence future cases involving the Prevnar-13 vaccine and Guillain-Barré Syndrome, as it sets a precedent regarding the standards of evidence required for such claims.
Looking ahead, Peterson's case is now closed, and there is no indication that it will be appealed. However, the legal landscape surrounding vaccine injury claims continues to evolve, and similar cases may arise in the future. The court's decision serves as a reminder of the rigorous scrutiny that vaccine injury claims undergo and the necessity for claimants to present compelling evidence to succeed.